● Recruiting

Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients

Condition: Burns · Sepsis · Septic Shock · Sponsor: Ain Shams University

PhaseNA

Planned participants70

Who can joinAll sexes, 25 Years to 60 Years

Healthy volunteersNo

About this study

The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early ICU discharge.

This description comes directly from the study's public registry record.

Talk to the study team

Ahmed H Elsayed, M.B.B.CH · +201016305451 · AhmedHanyAbdelfatah@med.asu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Ain Shams University

Cairo, Egypt

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06915974